Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · IEX Real-Time Price · USD
22.48
-0.52 (-2.26%)
Apr 24, 2024, 4:00 PM EDT - Market closed
Corcept Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for CORT stock have an average target of 35.6, with a low estimate of 29 and a high estimate of 42. The average target predicts an increase of 58.36% from the current stock price of 22.48.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CORT stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +69.04% | Apr 23, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $36 → $42 | Strong Buy | Maintains | $36 → $42 | +86.83% | Feb 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $28 | Strong Buy | Maintains | $34 → $28 | +24.56% | Jan 2, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $37 → $38 | Strong Buy | Maintains | $37 → $38 | +69.04% | Dec 13, 2023 |
| Truist Securities | Truist Securities | Hold → Strong Buy Upgrades $29 → $38 | Hold → Strong Buy | Upgrades | $29 → $38 | +69.04% | Nov 6, 2023 |
Financial Forecast
Revenue This Year
622.86M
from 482.38M
Increased by 29.12%
Revenue Next Year
679.08M
from 622.86M
Increased by 9.03%
EPS This Year
1.11
from 0.94
Increased by 18.28%
EPS Next Year
1.41
from 1.11
Increased by 26.38%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 653.1M | 743.4M | 827.5M | 960.3M | 1.2B |
| Avg | 622.9M | 679.1M | 799.7M | 831.0M | 976.1M |
| Low | 588.1M | 622.3M | 762.4M | 762.7M | 824.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 35.4% | 19.3% | 21.9% | 20.1% | 46.7% |
| Avg | 29.1% | 9.0% | 17.8% | 3.9% | 17.5% |
| Low | 21.9% | -0.1% | 12.3% | -4.6% | -0.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.58 | 1.55 | 2.27 | 2.88 | 4.19 |
| Avg | 1.11 | 1.41 | 2.08 | 2.50 | 3.30 |
| Low | 0.82 | 1.23 | 1.88 | 2.13 | 2.43 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 67.6% | 39.8% | 61.4% | 38.3% | 67.3% |
| Avg | 18.3% | 26.4% | 48.1% | 20.3% | 31.8% |
| Low | -12.4% | 10.2% | 33.9% | 2.2% | -2.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.